Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael Ferraresso | M | - | 7 years | |
Tom Maniatis | M | 80 |
Columbia University College of Physicians & Surgeons
| 14 years |
David Crist | M | - | 4 years | |
Anisha Wharton | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mark Alles | M | 64 | 15 years | |
Tuan Ha-Ngoc | M | 72 | 13 years | |
Kevin Koch | M | 63 | 15 years | |
Gregory Mayes | M | 55 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 11 years |
Henri A. Termeer | M | 78 | 6 years | |
Thomas Daniel | M | 70 | 10 years | |
Samuel D. Waksal | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 18 years |
Matthew D. Dallas | M | 49 | 7 years | |
Scott Smith | M | 61 | 10 years | |
Thomas Perone | M | 59 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 17 years |
Jay Backstrom | M | 69 | 11 years | |
Liam Ratcliffe | M | 60 | 2 years | |
Charles Baum | M | 65 | 5 years | |
Corinne Epperly | M | 46 | 2 years | |
Scarlett Spring | F | 60 | 4 years | |
Jeno Gyuris | M | 64 | 12 years | |
Daniel O'Connor | M | 59 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
Sandy Mahatme | M | 59 | 6 years | |
Keith S. Ehrlich | M | 73 | 2 years | |
Lisa M. Bruneau | F | - | 7 years | |
Karuna Rubin | F | 47 | 6 years | |
Daniel Lynch | M | 65 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
James J. Loughlin | M | 81 | 12 years | |
Joseph Vittiglio | M | 52 | 8 years | |
Raju S. Kucherlapati | M | 81 | 19 years | |
John W. Jackson | M | 78 | 10 years | |
Kevin J. Cullen | M | 67 | 2 years | |
Ernest Mario | M | 85 | 12 years | |
Erik D. Ramanathan | M | 52 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
William Rastetter | M | 75 | 6 years | |
Robert C. Young | M | 84 | 12 years | |
John L. Zabriskie | M | 85 | 12 years | |
Carrie Cox | F | 66 | 10 years | |
Rodman L. Drake | M | 80 | 8 years | |
Benjamin Winograd | M | 63 | 13 years | |
Catherine DeRose | F | - | 3 years | |
QI Bo | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
Gregory Russotti | M | 57 | 13 years | |
Lea Yared | F | - |
Columbia University College of Physicians & Surgeons
| 1 years |
Janice M. Smiell | M | - | 4 years | |
Fe Batara | F | - | 1 years | |
Alexander Reynolds | M | - | 13 years | |
Vijay Kasturi | M | 57 | 2 years | |
John Colin Ryan | M | - |
Columbia University College of Physicians & Surgeons
| 5 years |
Daniel Auclair | M | - |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | - |
Shawn Tomasello | F | 65 | 9 years | |
Philippe Martin | M | - | 7 years | |
Katherine Stultz | F | 50 | 15 years | |
Nikhil Mehta | M | 65 | 2 years | |
John F. Chin | M | 58 | 15 years | |
Peter Greaney | M | 45 | 12 years | |
Wai-Yip Lee | M | 51 | 5 years | |
Martin Bauknight | M | - |
Columbia University College of Physicians & Surgeons
| 4 years |
Axel Gaston Glasmacher | M | 64 | 12 years | |
Michael Pehl | M | 60 | 11 years | |
David Allmond | M | 54 | 6 years | |
Jian Ming Mei | M | 58 | 9 years | |
Keren Paz | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
Michele Korfin | F | 53 | 12 years | |
Rajesh Chopra | M | 63 | 7 years | |
Catherine B. Elflein | F | 63 | 14 years | |
Thomas Bock | M | 60 | 3 years | |
Joseph L. Fischer | M | 73 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
Carl Goldfischer | M | 65 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
John Johnson | M | 66 | 1 years | |
Arnold Levine | M | 84 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
Karen Brophy | F | 60 | 6 years | |
Eric Poma | M | 52 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
David Sidransky | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
Perry Karsen | M | 69 | 5 years | |
David Gryska | M | 68 | 4 years | |
Margaret Dalesandro | M | 77 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 7 years |
Catherine Vaczy | F | 62 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
Clifford Saffron | M | 67 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
Michael J. Howerton | M | 72 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 5 years |
Peter R. Borzilleri | M | 68 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
Frank T. Cary | M | 103 | 19 years | |
William W. Crouse | M | 80 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
Erick Lucera | M | 57 | 3 years | |
Jarl Ulf Birger Jungnelius | M | 73 | 7 years | |
Christina A. Waters | M | - |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | - |
Robert E. Winkler | M | 58 | - | |
Jean Bizzari | M | 69 | 7 years | |
Nicholas A. Saccomano | M | 65 | 5 years | |
Hai Ying He | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
George Golumbeski | M | 67 | 9 years | |
Quang M. Pham | M | 40 | 1 years | |
Jason Kim | M | 49 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
Andrew Bodnar | M | 75 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
Margery B. Fischbein | F | 68 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
Joseph S. Camardo | M | 69 | 10 years | |
Richard Crowley | M | 67 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
Ian Judson | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
Isaac E. Ciechanover | M | 53 | 6 years | |
John A. Fazio | M | 80 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
Leinee Hornbeck | F | - |
Columbia University College of Physicians & Surgeons
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael N. Needle
- Personal Network